GS

Gurudayalsing Soransing Juni

Active Director Director DIN 07413306
DIN 07413306 First appointment Feb 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurudayalsing Soransing Juni

Data last updated:

Gurudayalsing Soransing Juni is a Director at Phytology Pharma Private Limited (since 2016). The company operates in Chemicals.

DIN 07413306
Primary Designation Director
Industry Chemicals
First Appointment 08 Feb 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phytology Pharma Private Limited U24233MH2016PTC272894
Director08 Feb 20162016Active

Board colleagues of Gurudayalsing Soransing Juni

NameDINCompanyDesignation
Soreensing Gulabsing Juni07413307Phytology Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Phytology Pharma Private Limited
Premium access

Shareholding and investment profile for Gurudayalsing Soransing Juni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurudayalsing Soransing Juni

Gurudayalsing Soransing Juni currently holds 1 directorship: Phytology Pharma Private Limited (Director, since 08 Feb 2016).

Gurudayalsing Soransing Juni was first appointed on 08 Feb 2016 as Director at Phytology Pharma Private Limited.

The current boards of Gurudayalsing Soransing Juni's companies include Soreensing Gulabsing Juni (Phytology Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available